We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CCH:LSECoca-Cola HBC AG Analysis

Data as of 2026-06-13 - not real-time

£4,586.00

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Coca‑Cola HBC is riding a strong bullish technical backdrop, with the 20‑day SMA comfortably above the 50‑day and 200‑day averages, a bullish MACD histogram and an RSI hovering near the 70‑point over‑bought threshold. Price action remains above key support at 4,094 GBp and under the resistance near 4,594 GBp, while volume has been tapering, suggesting a potential short‑term consolidation. Fundamentally, the company delivers solid top‑line growth of roughly 7% YoY, healthy margins, a ROE above 25% and a sustainable dividend yield of 2.26% backed by a payout ratio under 40%. Analyst consensus remains a “buy” with median target prices modestly above the current level, indicating limited upside but a resilient earnings profile. The DCF valuation, however, sits well below the market price, flagging a degree of overvaluation despite the modest upside estimate of about 1%.
Overall, the defensive consumer sector positioning, low beta and strong cash generation mitigate many risks, though elevated debt levels and exposure to emerging‑market economies introduce medium‑level geographic and regulatory considerations. With the market sentiment in an “Extreme Greed” phase, investors should balance the attractive dividend and earnings resilience against the price premium and watch for any shift in volume or macro‑economic conditions that could pressure the stock.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 7/10

Key Factors

  • RSI near over‑bought levels
  • Decreasing volume indicating possible consolidation
  • Support level well‑defended

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Robust revenue growth and margin profile
  • Attractive dividend yield with sustainable payout
  • Analyst consensus and modest target price upside

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Strong cash flow generation and high ROE
  • Defensive consumer‑staples positioning
  • Long‑term dividend stability and growth potential

Key Metrics & Analysis

Financial Health

Revenue Growth7.30%
Profit Margin8.10%
P/E Ratio20.6
ROE25.96%
ROA7.56%
Debt/Equity99.27
P/B Ratio5.0
Op. Cash Flow£1.5B
Free Cash Flow£645.9M

Technical Analysis

TrendBullish
RSI70.0
Support£4,094.00
Resistance£4,594.40
MA 20£4,303.30
MA 50£4,297.61
MA 200£3,995.32
MACDBullish
VolumeDecreasing
Fear & Greed Index89.86

Valuation

Fair Value£2,861.24
Target Price£4,639.24
Upside/Downside1.16%
GradeFair
TypeBlend
Dividend Yield2.26%

Risk Assessment

Beta0.18
Volatility22.78%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.